Postoperative Anemia and Functional Outcomes After Fast-track Primary Hip Arthroplasty
1 other identifier
observational
125
1 country
2
Brief Summary
The purpose of this study is to evaluate the possible association between postoperative anaemia and functional outcomes the first 2 weeks after primary hip arthroplasty. The investigators hypothesise that patients with a higher degree of postoperative anaemia have impaired postoperative rehabilitation as measured by standardized functional outcome tests.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2012
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
January 17, 2012
CompletedFirst Posted
Study publicly available on registry
January 20, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2013
CompletedMarch 9, 2015
March 1, 2015
1.6 years
January 17, 2012
March 6, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
6 Minute walking test (6MWT)
6MWT is a standardized functional test which determines the walking distance covered during a timed period of 6 minutes.
2 weeks after surgery
Secondary Outcomes (3)
FACT-Anemia Scale
2 weeks after surgery
Timed up and go test (TUG)
2 weeks after surgery
At home activity by ActivPal
1 week after surgery
Study Arms (1)
Study Cohort
Patients, aged 65 or above, undergoing elective primary unilateral hip arthroplasty in a fast-track setting.
Eligibility Criteria
All patients aged 65 or above undergoing primary hip arhtroplasty
You may qualify if:
- Patients undergoing primary unilateral THA
- Age 65 or older
You may not qualify if:
- Not able to give consent
- Not able to walk prior to surgery
- Chronic need for RBC transfusion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rigshospitalet, Denmarklead
- University Hospital, Gentofte, Copenhagencollaborator
- Vejle Hospitalcollaborator
Study Sites (2)
Gentofte Hospital, Department of orthopedic surgery
Gentofte Municipality, Denmark
Vejle Sygehus, Department of orthopedic surgery
Vejle, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Oeivind Jans, MD.
Rigshospitalet, Denmark
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD., Research Fellow
Study Record Dates
First Submitted
January 17, 2012
First Posted
January 20, 2012
Study Start
January 1, 2012
Primary Completion
August 1, 2013
Study Completion
August 1, 2013
Last Updated
March 9, 2015
Record last verified: 2015-03